NCT04735367 Study to Evaluate Overall Survival in Japanese Patients With HR+/HER2- Advanced Breast Cancer Treated With Palbociclib Plus Letrozole Status COMPLETED Phase N/A
NCT04735068 Binimetinib and Hydroxychloroquine in Patients With Advanced KRAS Mutant Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT04724421 Expanded Access Protocol for Adults and Pediatric Patients With Sickle Cell Disease Who Have No Alternative Treatment Options Status NO_LONGER_AVAILABLE Phase N/A
NCT04721977 A Study of Tucatinib (MK-7119) in Combination With Trastuzumab and Capecitabine in Participants With Previously Treated Locally Advanced Unresectable or Metastatic Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Breast Carcinoma (MK-7119-001) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04721821 Comparative Effectiveness Of Tumor Necrosis Factor Inhibitors And Tofacitinib Use In Earlier Lines Of Therapy And Use As Monotherapy. Status COMPLETED Phase N/A
NCT04721808 A Study To Investigate And Describe The Treatment Patterns And Effect Of Tofacitinib Indicators For Patients With Rheumatoid Arthritis Status COMPLETED Phase N/A
NCT04716621 Computerized Decision Support Tool for Pain Management in Primary Care Status COMPLETED Phase NA
NCT04713553 A Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of Multiple Production Lots and Dose Levels of BNT162b2 RNA-Based COVID-19 Vaccines Against COVID-19 in Healthy Participants Status COMPLETED Phase PHASE3
NCT04707313 A Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Obesity Status COMPLETED Phase PHASE2
NCT04706793 Oral Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis in Adult Japanese Participants (ELEVATE UC 40 JAPAN) Status COMPLETED Phase PHASE3
NCT04703920 Talazoparib in Combination With Belinostat for Metastatic Breast Cancer, Metastatic Castration Resistant Prostate Cancer, and Metastatic Ovarian Cancer Status COMPLETED Phase PHASE1
NCT04697381 Study of the Efficacy and Safety of Somatropin in Japanese Participants With PWS Status COMPLETED Phase PHASE3
NCT04690855 A Study to Evaluate TAlazoparib, Radiotherapy and Atezolizumab in gBRCA 1/2 Negative Patients With PD-L1+ Metastatic Triple Negative Breast Cancer Status TERMINATED Phase PHASE2
NCT04682639 A Study to Assess the Safety and Efficacy of Oral Etrasimod in Adult Participants With Eosinophilic Esophagitis Status COMPLETED Phase PHASE2
NCT04682587 To Examine the Effects of Axitinib Dose Reduction and Interruption for Adverse Event Management Among Patients Receiving Axitinib in for the Treatment of Advanced Renal Cell Carcinoma Status COMPLETED Phase N/A
NCT04681482 Effectiveness And Safety Of Oral Anticoagulants Among Obese Patients With Non-Valvular A-Fib In VA Patients With Medicare Status COMPLETED Phase N/A
NCT04678362 TALazoparib and Avelumab as Maintenance Therapy in Platinum-Sensitive Metastatic or Locally Advanced URothelial Carcinoma Status RECRUITING Phase PHASE2
NCT04672460 A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT04671615 A Study to Understand the Treatment Patterns and Patients and Their Clinical Outcomes Who Are Taking Palbociclib in a Real Life Setting in Israel. Status COMPLETED Phase N/A